SK Biopharmaceuticals Co., Ltd.

₩88,800As of Sun 8 Nov 2026, 12:00 UTC
KRX:326030Healthcare
Country South Korea
PE (Fwd) •••
TSR 6Y CAGR (10.81%)
Div yield —
ROE 47.92%
Biotechnology
Beta (5Y) 0.66
PE TTM 17.34
TSR TTM (23.12%)
Mkt cap ₩6.954T
ROIC 44.59%
SE Grade™
Value
Quality
Moat
Consensus
Reference
₩113,497
27.81%
(79.10%)
Hold 6|8|2|6|3
4Q25
1Q26
2Q26
3Q26
Earnings per share₩
899.87
906.62
944.77
899.72
3.66%
3.06%
8.93%
5.45%
Revenue₩B
451.3
445.6
436.3
442.0
7.92%
3.97%
0.18%
(4.10%)
Peers (US$5.127B)
Cap (US$)
PE
10.29B
76.81x
3.063B
—
5.040B
—
Capital
TTM
5Y
10Y
Leveragex
0.349
6.643
5.263
EBIT/Intx
5.856
0.160
0.148
Own earn%
5.43
88.30
88.81
Sh yield%
29.01
33.17
34.41
Owners
Insiders/Inst%
7.84
59.05
Short interest%
5.41
SBC / revenue%
4.11
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
20
Op margin range%
2–8
$1 testx
1.8
Incr. ROIC%
16